Jacobson Pharma Launches Smartfish Health Nutrition Products from Norway in Greater China and Asia Pacific Region
HONG KONG, Nov 12, 2019 - (ACN Newswire) - Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Group"; Stock Code: 2633), a leading company engaging in research, development, production, marketing and sale of generic drugs and proprietary medicines, announced the launch of Smartfish's health nutrition range of products in Greater China (including Mainland China, Hong Kong, Macau and Taiwan) and Asia under an exclusive distribution agreement with Smartfish AS, a branded health nutrition company incorporated in Norway.
| Photo Caption (1): Smartfish products for the consumer health nutrition range; Photo Caption (2): Smartfish is the official supplier of sports nutrition drinks to sports clubs and national teams, including English Premier League Tottenham Hotspurs Football Club |
According to the agreement, the Group has an in-licensed right for 10 years to distribute and market Smartfish's consumer health products in Greater China and the Asia Pacific Region, covering four product ranges, namely "Smartfish Recharge" for sports nutrition, "Smartfish Resolve" for improving metabolic health and diabetes care, "Smartfish Reflect" for promoting adults' brain health and cognitive function, and "Smartfish Cream" for benefiting children's brain development
Built upon a patented emulsion technology and clinically substantiated, Smartfish's Omega-3-enhanced nutritional drinks and emulsion products complement the fast-growing medical and consumer nutrition markets with products of evidence-based health benefits.
Differentiated from standard fish oil supplements, Smartfish's emulsion carries high levels of Omega 3 fatty acids, in synergy with other nutrients, that can produce the potentiating anti-inflammatory effects to deliver various health benefits . It can also ensure a tasty delivery of nutrients by protecting Omega-3 fatty acids, which are rich in fish oil, from oxidizing and forming the rancid taste. The products are clinically tested, and all health benefit claims for Smartfish products are supported by rigorous science.
Smartfish's products range provides health nutrition for the elderly and the young, medical nutrition for chronic disease patients, and sports nutrition for athletes. Smartfish has established itself as a trusted nutritional source for professional athletes worldwide being the official supplier of sports nutrition drinks to sports clubs and national teams, which include English Premier League Tottenham Hotspurs Football Club and Norwegian Nordic Combined National Team of Skiing.
Jacobson Pharma's strategic collaboration with Smartfish also included a shareholding investment of 9.04% of Smartfish's issued capital made in July 2019, which is expected to forge a stronger partnership and platform for both companies on exploring potential business cooperation in the high growing consumer health nutrition market in the future.
Mr. Derek Sum, Chairman and Chief Executive Officer of Jacobson Pharma, comments, "We welcome Smartfish's nutrition products with well-documented potency to our consumer health product portfolio. The health nutrition market has witnessed strong growth driven by the greater inclination towards self-care and health problems prevention, alongside a growing aged population and increase in disposable income. Through this collaboration, Jacobson Pharma has primed itself to collaborate with Smartfish in exploiting the latent demand for clinically substantiated health nutrition products to meet different lifestyle and healthcare needs among consumers in Greater China and the Asia Pacific Region."
About Jacobson Pharma Corporation Limited (Stock Code: 2633) Jacobson Pharma is a leading generic drug company in Hong Kong. The Group's proprietary brand portfolio, notably being Po Chai Pills, Ho Chai Kung Tji Thung San, Contractubex Scar Gel, Flying Eagle Wood Lok Medicated Oil, Tong Tai Chung Woodlok Oil, Doan's Ointment, Saplingtan, Shiling Oil and Col-gan Tablet have been widely recognised by the market. The Group aims to enrich its portfolio through addition of high value-added products covering sterile injections, oncology products as well as orphan drugs and biosimilars. With its corporate headquarters based in Hong Kong, the Group has also established its operating subsidiaries in China, Macau, Taiwan, Singapore and Cambodia forming a regional commercial platform to tap the market potential in the Asia Pacific and Greater China region. Jacobson Pharma has been a constituent stock of MSCI Hong Kong Micro Cap Index since 1 June 2017. For more details about Jacobson Pharma, please visit the Group's website: http://www.jacobsonpharma.com
About Smartfish AS Smartfish is a company incorporated in Norway which focuses on research & development, production and marketing of advanced, science-based and clinically documented nutritional products. Smartfish provides unique nutritional solutions for both medical use and consumer health. Its nutrition products are based on a proprietary emulsion technology that enables the effective delivery of high levels of Omega 3 fatty acids, whey protein and other nutrients. Smartfish has a number of ongoing clinical development projects and studies in the pipeline in close collaboration with renowned researchers and institutions around the world. The company was founded in 2001 and is now headquartered in Oslo, Norway with an operating subsidiary in Lund, Sweden. Smartfish's main shareholders include Investinor (a Norwegian-based fund) and Industrifonden (a Nordic fund). Learn more on www.smartfishnutrition.com.
For media enquiries, please contact: Strategic Financial Relations Limited Vicky Lee Tel: (852) 2864 4834 Email: vicky.lee@sprg.com.hk Stephanie Liu Tel: (852) 2864 4852 Email: stephanie.liu@sprg.com.hk Tika Lum Tel: (852) 2864 4806 Email: tika.lum@sprg.com.hk Fax: (852) 2527 1196
Source: Jacobson Pharma Corporation Limited Sectors: Daily Finance, Healthcare & Pharm
Copyright ©2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|
Latest Release
Eisai Completes Rolling Submission to US FDA for LEQEMBI(R) (lecanemab-irmb) Biologics License Application for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer's Disease Under the Fast Track Status Nov 01, 2024 13:56 JST
| All-New Triton Wins Golden Award at VMARK Vietnam Design Awards 2024 Nov 01, 2024 12:43 JST
| Fujitsu's groundbreaking computing technology for accelerating scientific computing wins Japan Patent Office Commissioner's Award Nov 01, 2024 12:24 JST
| Fujitsu and AMD to begin strategic partnership to develop more sustainable computing infrastructure intended to accelerate open-source AI initiatives Nov 01, 2024 10:45 JST
| Mazda Launches Redesigned Corporate Website Oct 31, 2024 17:06 JST
| NTT and Toyota Motor Corporation agree to joint initiative in the field of mobility and AI/telecommunications with the aim of realizing a society with zero traffic accidents Oct 31, 2024 16:34 JST
| All-New Triton Wins Golden Award at VMARK Vietnam Design Awards 2024 Oct 31, 2024 16:08 JST
| Eisai Presents Data on Benefits of Long-Term Administration of Dual-Acting Lecanemab at the 17th Clinical Trials for Alzheimer's Disease (CTAD) Conference Oct 31, 2024 13:56 JST
| Eisai Presents Latest Clinical Findings Suggesting Inhibition of Tau Propagation by Anti-MTBR Tau Antibody E2814 at the 17th Clinical Trials on Alzheimer's Disease Conference (CTAD) Oct 31, 2024 11:33 JST
| Mazda Production and Sales Results for September 2024 and for April through September 2024 Oct 30, 2024 17:09 JST
| Suzuki and Toyota to Deepen Collaboration in the Field of Electrified Vehicles Oct 30, 2024 16:14 JST
| Fujitsu and Morinaga Milk Industry jointly develop a simulation system for raw material price fluctuations, speeding up decision-making Oct 30, 2024 13:43 JST
| DOCOMO to Participate in Virtual Expo at Expo 2025 Osaka, Kansai, Japan Oct 30, 2024 12:47 JST
| ULVAC Launches Technology Center PYEONGTAEK for Next-Gen Semiconductor Manufacturing Equipment in South Korea Oct 30, 2024 11:00 JST
| Fujitsu and Linius partner to unlock the power of video worldwide Oct 29, 2024 19:53 JST
| DENSO and U.S. Startup Quadric Sign Development License Agreement for AI Semiconductor (NPU) Oct 29, 2024 13:03 JST
| Toyota Motor Corporation and Hyundai Motor Company Co-host Motorsport Event to Share the Excitement of Racing Oct 28, 2024 20:53 JST
| NEC launches new end to end private 5G solution with Cisco Oct 28, 2024 17:05 JST
| Mitsubishi Power Receives Order for Facility Retrofit at the Darajat Geothermal Power Plant in Indonesia Oct 28, 2024 15:35 JST
| GS Holdings to Acquire Integrated Beverage Solutions Group, Octopus Distribution Networks, for S$11.8 Million; Expected to Yield Significant Opportunities and Additional Financial Benefits Oct 28, 2024 09:00 JST
|
More Latest Release >>
|